Trial Profile

Phase 3 trial for BOLD-100 in the treatment of advanced colorectal cancer

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 06 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BOLD 100 (Primary)
Indications Colorectal cancer
Focus Registrational; Therapeutic Use

Most Recent Events

01 Jun 2023 According to a Bold Therapeutics media release, the company expect to initiate this trial in 2024.
20 Apr 2023 New trial record
18 Apr 2023 According to a Bold Therapeutics media release, the company expect to initiate this trial in near future.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com